Search Within

Mark Kris

Formats
  1. Journal Article (481)
  2. Meeting Abstract (356)
  3. Conference Paper (16)
  4. Book Section (9)
  5. Review (6)
  6. Guidelines (2)
  7. Editorial (1)
  8. Miscellaneous (1)
  9. Research Letter (1)
Groups
  1. Department of Medicine (873)
  2. Solid Tumor Oncology Division (873)
  3. Thoracic Oncology (873)
  4. Department of Pathology and Laboratory Medicine (325)
  5. GSK Faculty (293)
  6. Human Oncology and Pathogenesis Program (226)

More Groups

People
  1. Gregory Riely (222)
  2. Marc Ladanyi (191)
  3. Vincent Miller (172)
  4. Valerie Rusch (130)
  5. Maria Arcila (124)
  6. Jamie Chaft (107)

More People

Years
  1. 2025 (8)
  2. 2024 (18)
  3. 2023 (27)
  4. 2022 (21)
  5. 2021 (21)
  6. 2020 (25)

More Years

Publications
  1. Journal of Clinical Oncology (235)
  2. Journal of Thoracic Oncology (131)
  3. Clinical Cancer Research (65)
  4. Cancer (33)
  5. Lung Cancer (31)
  6. Annals of Oncology (25)

More Publications

Publishers
  1. American Society of Clinical Oncology (253)
  2. Elsevier Inc. (179)
  3. American Association for Cancer Research (105)
  4. Oxford University Press (48)
  5. Wiley Blackwell (36)
  6. Elsevier Ireland Ltd. (30)

More Publishers

Results (873)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Malignant pleural mesothelioma: Clinical practice guidelines in oncology
    Journal Article

    Ettinger, D. S.; Akerley, W.; Borghaei, H.; Chang, A.; Cheney, R. T.; Chirieac, L. R.; D'Amico, T. A.; Demmy, T. L.; Ganti, A. K. P.; Govindan, R.; more...
    Journal of the National Comprehensive Cancer Network (2012)

    Fulltext@MSK | Save
  • Can we really treat patients older than age 70 with a chemotherapy doublet for non-small cell lung cancer (NSCLC)?
    Meeting Abstract

    Zauderer, M. G.; Sima, C. S.; Korc-Grodzicki, B.; Kris, M. G.; Krug, L. M.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Identification of driver mutations in tumor specimens from 1,000 patients with lung adenocarcinoma: The NCI's Lung Cancer Mutation Consortium (LCMC)
    Meeting Abstract

    Kris, M. G.; Johnson, B. E.; Kwiatkowski, D. J.; Iafrate, A. J.; Wistuba, I. I.; Aronson, S. L.; Engelman, J. A.; Shyr, Y.; Khuri, F. R.; Rudin, C. M.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Clinical, pathologic, and molecular characteristics of patients with non-small cell lung cancer harboring mutations in PIK3CA
    Meeting Abstract

    Pietanza, M. C.; Arcila, M. E.; Chaft, J. E.; Zakowski, M. F.; Ladanyi, M.; Riely, G. J.; Kris, M. G.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Maintained sensitivity to EGFR tyrosine kinase inhibitors (TKIs) in EGFR-mutant lung cancers that recur after adjuvant TKI
    Meeting Abstract

    Oxnard, G. R.; Janjigian, Y. Y.; Arcila, M. E.; Kris, M. G.; Ladanyi, M.; Azzoli, C. G.; Miller, V. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Response to EGFR TKIs in never smokers with stage IV EGFR mutant squamous cell carcinoma of the lung (SQCC)
    Meeting Abstract

    Paik, P. K.; Rekhtman, N.; Riely, G. J.; Miller, V. A.; Ladanyi, M.; Kris, M. G.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Randomized, double-blinded, phase II trial of a WT1 peptide vaccine as adjuvant therapy in patients with malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Krug, L. M.; Tsao, A. S.; Kass, S.; Rusch, V. W.; Travis, W. D.; Panageas, K.; Adusumili, P. S.; Kris, M. G.; Maslak, P. G.; Scheinberg, D. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Immunogenicity of GI-4000 vaccine in adjuvant consolidation therapy following definitive treatment in patients with stage I-III adenocarcinoma of the lung with G12C, G12D, or G12V KRAS mutations
    Meeting Abstract

    D'Angelo, S. P.; Park, B. J.; Krug, L. M.; Crevar, C.; Medina, C. E.; Sumner, D. K.; Richman, J.; Coeshott, C.; Apelian, D.; Cohn, A.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Disease flare after tyrosine kinase inhibitor (TKI) discontinuation in patients with EGFR-mutant lung cancer and acquired resistance
    Meeting Abstract

    Chaft, J. E.; Oxnard, G. R.; Miller, V. A.; Kris, M. G.; Sima, C. S.; Riely, G. J.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Small cell and neuroendocrine tumors of the lung
    Book Section

    Krug, L. M.; Pietanza, M. C.; Kris, M. G.; Rosenzweig, K.; Travis, W. D.
    In DeVita, V. T. Jr; Lawrence, T. S.; Rosenberg, S. A. (Eds.) DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 9th ed (2011)

    Fulltext@MSK | Save